1. Home
  2. SLDB vs ZUMZ Comparison

SLDB vs ZUMZ Comparison

Compare SLDB & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • ZUMZ
  • Stock Information
  • Founded
  • SLDB 2013
  • ZUMZ 1978
  • Country
  • SLDB United States
  • ZUMZ United States
  • Employees
  • SLDB N/A
  • ZUMZ N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • ZUMZ Clothing/Shoe/Accessory Stores
  • Sector
  • SLDB Health Care
  • ZUMZ Consumer Discretionary
  • Exchange
  • SLDB Nasdaq
  • ZUMZ Nasdaq
  • Market Cap
  • SLDB 234.8M
  • ZUMZ 211.6M
  • IPO Year
  • SLDB 2018
  • ZUMZ 2005
  • Fundamental
  • Price
  • SLDB $4.73
  • ZUMZ $14.49
  • Analyst Decision
  • SLDB Strong Buy
  • ZUMZ Hold
  • Analyst Count
  • SLDB 10
  • ZUMZ 1
  • Target Price
  • SLDB $15.10
  • ZUMZ $25.00
  • AVG Volume (30 Days)
  • SLDB 2.0M
  • ZUMZ 318.4K
  • Earning Date
  • SLDB 08-12-2025
  • ZUMZ 06-05-2025
  • Dividend Yield
  • SLDB N/A
  • ZUMZ N/A
  • EPS Growth
  • SLDB N/A
  • ZUMZ N/A
  • EPS
  • SLDB N/A
  • ZUMZ 0.04
  • Revenue
  • SLDB N/A
  • ZUMZ $896,157,000.00
  • Revenue This Year
  • SLDB N/A
  • ZUMZ $3.31
  • Revenue Next Year
  • SLDB N/A
  • ZUMZ $1.34
  • P/E Ratio
  • SLDB N/A
  • ZUMZ $330.32
  • Revenue Growth
  • SLDB N/A
  • ZUMZ 3.01
  • 52 Week Low
  • SLDB $2.41
  • ZUMZ $11.31
  • 52 Week High
  • SLDB $10.37
  • ZUMZ $31.37
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 59.76
  • ZUMZ 64.27
  • Support Level
  • SLDB $4.49
  • ZUMZ $12.52
  • Resistance Level
  • SLDB $5.16
  • ZUMZ $13.06
  • Average True Range (ATR)
  • SLDB 0.41
  • ZUMZ 0.54
  • MACD
  • SLDB -0.02
  • ZUMZ 0.15
  • Stochastic Oscillator
  • SLDB 47.37
  • ZUMZ 95.70

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

Share on Social Networks: